Peri-implant Soft Tissue HealingNCT07031232
Comparative Clinical Study of Conventional vs Customized Healing Abutments in Dental Implantology
A study testing Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments in people with Peri-implant Soft Tissue Healing and Soft Tissue Management in Subcrestal Dental Implants, run by University of Valencia at 1 site in Spain.
Trial summary
This clinical study evaluates how different healing abutment designs influence the healing and preservation of the soft tissues surrounding dental implants. Healing abutments are temporary components placed on implants during the healing phase to help shape the gum tissue before placing the final crown or prosthesis. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Peri-implant Soft Tissue Healing, Soft Tissue Management in Subcrestal Dental Implants, Healing Abutment Influence on Gingival Volume
- What is being tested?
- Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 75 participants
- Where
- 1 siteSpain
- Study dates
- 1 Jul 2025to 31 Jul 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Adults aged 18 years or older.
- Patients requiring a single dental implant in a healed posterior site (maxilla or mandible).
- Presence of at least 2 mm of keratinized mucosa at the implant site.
- Healed alveolar ridge with sufficient bone volume for implant placement without need for guided bone regeneration.
- Good general and oral health, with controlled plaque and bleeding indices.
- Insertion torque ≥ 30 Ncm at the time of implant placement.
- Willingness to comply with study protocol and attend scheduled follow-up visits.
- Signed informed consent.
Who cannot join
- Smoking more than 10 cigarettes per day.
- Uncontrolled systemic diseases (e.g., uncontrolled diabetes, immunosuppression).
- History of head or neck radiation therapy.
- Current or recent use of bisphosphonates.
- Active periodontal disease or peri-implant infection.
- Severe parafunctional habits (e.g., bruxism, clenching).
- Pregnant or breastfeeding women.
- Previous implant failure at the intended site.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Assessment of Peri-implant Soft Tissue Modifications Following the Use of Customized Healing Abutments on Subcrestally Placed Implants
This clinical study evaluates how different healing abutment designs influence the healing and preservation of the soft tissues surrounding dental implants. Healing abutments are temporary components placed on implants during the healing phase to help shape the gum tissue before placing the final crown or prosthesis. The way these components interact with the gum tissue may affect the long-term stability, volume, and aesthetics of the peri-implant soft tissue.
All participating patients will receive bone-level dental implants placed approximately 2 mm below the bone crest (subcrestal position). The study will include three groups of patients, each receiving a different type of healing abutment:
Read more
Group 1 (Control): will receive a standard cylindrical healing abutment.
Group 2: will receive a wide healing abutment with an enlarged base to support more soft tissue volume.
Group 3: will receive a customized healing abutment designed using digital intraoral scanning and CAD/CAM technology, intended to replicate the final prosthetic emergence profile.
The goal is to evaluate which type of healing abutment helps to preserve the natural volume and shape of the gum tissue most effectively during the healing period. The primary focus will be on measuring changes in soft tissue volume and thickness around the implants over time.
Participants will undergo digital intraoral scans before surgery and at 3, 6, and 12 months after implant placement. These scans will be used to assess how the gum tissue changes in response to each type of abutment using 3D analysis and software-based measurements.
This study is important because maintaining healthy and stable soft tissue around dental implants plays a crucial role in achieving successful, long-lasting, and aesthetically pleasing results. By understanding how healing abutment design affects tissue healing, clinicians may be better equipped to select the most appropriate healing protocol for each patient.
Read the detailed description
Background and Rationale:
Peri-implant soft tissue health and stability are essential factors influencing the long-term success of dental implants, especially in terms of aesthetic outcomes and biological integration. A well-formed and stable mucosal seal around the implant protects the underlying bone, supports tissue homeostasis, and contributes to the overall functional and esthetic result of implant-supported prostheses.
Healing abutments are temporary components used during the transgingival healing phase to help shape the emergence profile and guide soft tissue adaptation prior to final prosthetic restoration. The design, diameter, and customization of the healing abutment may significantly affect peri-implant soft tissue volume, thickness, contour, and recession patterns. Recent research has suggested that minimizing disruption to the peri-implant mucosa (i.e., using a one abutment-one time approach) and optimizing soft tissue support during healing can result in improved tissue preservation and enhanced esthetic outcomes.
However, there is limited clinical evidence comparing the effect of different healing abutment designs-particularly standard, wide, and customized abutments-on the volumetric and linear changes in peri-implant soft tissues, especially when implants are placed subcrestally in healed ridges. This study aims to address that gap through a randomized controlled clinical trial using modern digital tools for volumetric analysis.
Study Objectives:
Primary Objective:
To compare the volumetric changes in peri-implant soft tissue among three different healing abutment designs (standard, wide, and customized) placed over subcrestally positioned bone-level implants in healed ridges.
Secondary Objectives:
To assess the linear changes in gingival margin position and mucosal thickness.
To evaluate the influence of healing abutment design on the stability of the emergence profile.
To explore potential correlations between abutment geometry and soft tissue recession or contour collapse.
To analyze patient-reported outcomes related to esthetic satisfaction and perceived tissue healing.
Study Design:
This is a single-center, randomized, controlled, parallel-group clinical trial with three intervention arms. Thirty adult patients will be recruited and randomly allocated into one of the three study groups (n = 25 per group). All patients will receive a single bone-level dental implant in a posterior maxillary or mandibular healed site, placed 2 mm subcrestally following a one abutment-one time protocol with platform switching.
Study Groups:
Group 1 (Control Group):
Standard cylindrical titanium healing abutment (prefabricated, regular diameter).
Group 2 (Wide Abutment Group):
Prefabricated wide healing abutment with increased diameter for broader mucosal support.
Group 3 (Customized Abutment Group):
Customized healing abutment fabricated in composite using preformed emergence profiles to replicate the ideal emergence profile of the final prosthesis.
All healing abutments will be placed at the time of implant surgery and will not be disconnected during the healing process, in accordance with the one abutment-one time philosophy.
Inclusion Criteria:
Adults aged 18 years or older.
Non-smoking or light-smoking patients (<10 cigarettes/day).
Good general and oral health.
Healed posterior edentulous site requiring a single implant.
Presence of ≥2 mm of keratinized mucosa.
Bone volume sufficient for subcrestal implant placement without grafting.
Willingness to participate and follow the study protocol.
Exclusion Criteria:
Active periodontal or peri-implant disease.
Systemic diseases affecting healing (e.g., uncontrolled diabetes).
Use of bisphosphonates or immunosuppressants.
Pregnancy or lactation.
History of radiation therapy in the head and neck.
Parafunctional habits (e.g., severe bruxism).
Intervention Protocol:
Surgical Procedure:
All implants will be placed 2 mm subcrestally using a guided surgical protocol.
After implant placement, patients will receive the assigned healing abutment (standard, wide, or customized) immediately.
The abutment will remain in place throughout healing and prosthetic phases.
Digital Workflow:
Intraoral scans (STL files) will be obtained at:
T0 (baseline, immediately post-surgery),
T1 (3 months),
T2 (6 months),
T3 (12 months).
The STL files will be superimposed using best-fit alignment algorithms for accurate 3D comparisons.
Tissue Measurement and Analysis:
Soft tissue changes will be measured in terms of:
Volumetric displacement (mm³) using specialized 3D software.
Linear changes in soft tissue thickness and mucosal margin level (mm).
Qualitative heat maps and color-coded deviations will be used to visualize soft tissue gain/loss.
Primary Outcome Measure:
Change in buccal soft tissue volume (mm³) from baseline to 3 months, based on digital 3D superimposition and volumetric analysis.
Secondary Outcome Measures:
Linear change in mucosal thickness (mm) at 3, 6, and 12 months.
Gingival margin displacement (mm) at buccal and interproximal points.
Stability of the emergence profile during provisional and final restoration stages.
Patient-reported esthetic satisfaction using a visual analog scale (VAS).
Statistical Analysis:
Descriptive and inferential statistics will be used. Continuous variables will be analyzed with repeated measures ANOVA or mixed models. Categorical variables will be evaluated using chi-square or Fisher's exact tests. A p-value < 0.05 will be considered statistically significant.
Sample size was calculated to detect a clinically significant difference of 1 mm³ in soft tissue volume change, with a standard deviation of 0.8, α = 0.05, and 80% power, resulting in 10 subjects per group.
Ethical Considerations:
The study will be conducted in accordance with the Declaration of Helsinki and Good Clinical Practice (GCP) guidelines. Ethical approval has been or will be obtained from the institutional review board. Informed consent will be obtained from all participants prior to any study-related procedure.
Expected Outcomes and Significance:
This clinical trial aims to clarify how the design of healing abutments-particularly customized CAD/CAM components-affects the healing and dimensional stability of peri-implant soft tissues. Results from this study could support evidence-based decision-making regarding abutment selection in clinical practice, especially in aesthetic-sensitive or high-demand cases. Improved tissue preservation could lead to better prosthetic outcomes and patient satisfaction.
- Conditions
- Peri-implant Soft Tissue Healing, Soft Tissue Management in Subcrestal Dental Implants, Healing Abutment Influence on Gingival Volume
- Being tested
- Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing AbutmentsProcedure or surgery
All participants will receive a single bone-level dental implant placed in a healed posterior site of the maxilla or mandible. The implants will be placed using a biological drilling protocol and inserted with a final torque of at least 30 Ncm. A 2 mm transmucosal one-piece abutment (mono-block) will be connected at the time of surgery, following a one abutment-one time philosophy.
Each patient will receive a healing abutment immediately after implant placement according to their allocated study group (standard, wide, or customized). The assigned healing abutment will not be removed throughout the healing period. All procedures will be carried out under local anesthesia in a standard clinical setting.
| Study group | Role | What they receive |
|---|---|---|
| Standard Healing Abutment Group | Experimental | Participants in this group will receive a conventional, prefabricated cylindrical titanium healing abutment placed immediately after implant surgery. The abutment will remain in place throughout the healing period, following a one abutment-one time protocol. Receives: Procedure: Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments |
| Wide Healing Abutment Group | Experimental | Participants in this group will receive a prefabricated wide healing abutment with an increased diameter designed to provide broader mucosal support. The abutment will be placed immediately after surgery and will not be removed during healing. Receives: Procedure: Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments |
| Customized Healing Abutment Group | Experimental | Participants in this group will receive a customized healing abutment fabricated with composite using a preform-phantoma. The abutment will replicate the desired emergence profile of the final prosthesis. It will be placed immediately after surgery and left in place during the healing phase. Receives: Procedure: Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments |
What is being measured
The primary outcome is the main question the study is designed to answer.
Dimensional changes in the peri-implamt soft tissue
Soft tissue changes will be assessed using digital intraoral scans obtained at baseline, immediately after surgery, and at 3, 6, and 12 months. STL files will be superimposed using 3D analysis software based on stable anatomical landmarks. Volumetric and linear changes will be calculated within defined buccal and interproximal regions of interest (ROIs). Parameters include soft tissue volume (mm³), thickness (mm), and gingival margin displacement. Color-coded deviation maps will visualize contour stability. All measurements will be performed in duplicate by calibrated, blinded evaluators. This method offers accurate, reproducible, and non-invasive assessment of peri-implant soft tissue dynamics.
Measured: Preoperative, the day of the intervention and a follow up until 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jun 2025
- Study start1 Jul 2025
- Primary completion31 Oct 2026 (estimated)
- Study completion31 Jul 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Peri-implant Soft Tissue HealingStudies of the same condition, open and under way.
- More trials run by University of ValenciaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 75 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Valencia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Juan Carlos Bernabeu Mira, University of Valencia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07031232
- Sponsor's protocol ID
- UV-INV_ETICA-3494808
- Status last verified
- Jul 2026
- First submitted
- 12 Jun 2025
- Last updated
- 7 Jul 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Perez A, Caiazzo A, Valente NA, Toti P, Alfonsi F, Barone A. Standard vs customized healing abutments with simultaneous bone grafting for tissue changes around immediate implants. 1-year outcomes from a randomized clinical trial. Clin Implant Dent Relat Res. 2020 Feb;22(1):42-53. doi: 10.1111/cid.12871. Epub 2019 Dec 3.
PubMed 31797548Chokaree P, Poovarodom P, Chaijareenont P, Rungsiyakull P. Effect of Customized and Prefabricated Healing Abutments on Peri-Implant Soft Tissue and Bone in Immediate Implant Sites: A Randomized Controlled Trial. J Clin Med. 2024 Feb 2;13(3):886. doi: 10.3390/jcm13030886.
PubMed 38337580Puisys A, Auzbikaviciute V, Vindasiute-Narbute E, Pranskunas M, Razukevicus D, Linkevicius T. Immediate implant placement vs. early implant treatment in the esthetic area. A 1-year randomized clinical trial. Clin Oral Implants Res. 2022 Jun;33(6):634-655. doi: 10.1111/clr.13924. Epub 2022 Apr 7.
PubMed 35318752Akin R, Chapple AG. Clinical Advantages of Immediate Posterior Implants With Custom Healing Abutments: Up to 8-Year Follow-Up of 115 Cases. J Oral Maxillofac Surg. 2022 Dec;80(12):1952-1965. doi: 10.1016/j.joms.2022.08.014. Epub 2022 Aug 30.
PubMed 36155739
Study at a glance
From the registry record, last updated by the sponsor on 7 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Peri-implant Soft Tissue Modifications Following the Use of Customized Healing Abutments on Subcrestally Placed Implants
- ClinicalTrials.gov ID
- NCT07031232
- Acronym / sponsor ID
- UV-INV_ETICA-3494808
- Conditions
- Peri-implant Soft Tissue Healing, Soft Tissue Management in Subcrestal Dental Implants, Healing Abutment Influence on Gingival Volume
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 75 participants (estimated)
- Lead sponsor
- University of ValenciaUniversity, hospital or other
- Study start
- 1 Jul 2025 (actual)
- Primary completion
- 31 Oct 2026 (estimated)
- Study completion
- 31 Jul 2029 (estimated)
- First posted
- 22 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This clinical study evaluates how different healing abutment designs influence the healing and preservation of the soft tissues surrounding dental implants. Healing abutments are temporary components placed on implants during the healing phase to help shape the gum tissue before placing the final crown or prosthesis. The way these components interact with the gum tissue may affect the long-term stability, volume, and aesthetics of the peri-implant soft tissue.
All participating patients will receive bone-level dental implants placed approximately 2 mm below the bone crest (subcrestal position). The study will include three groups of patients, each receiving a different type of healing abutment:
Group 1 (Control): will receive a standard cylindrical healing abutment.
Group 2: will receive a wide healing abutment with an enlarged base to support more soft tissue volume.
Group 3: will receive a customized healing abutment designed using digital intraoral scanning and CAD/CAM technology, intended to replicate the final prosthetic emergence profile.
The goal is to evaluate which type of healing abutment helps to preserve the natural volume and shape of the gum tissue most effectively during the healing period. The primary focus will be on measuring changes in soft tissue volume and thickness around the implants over time.
Participants will undergo digital intraoral scans before surgery and at 3, 6, and 12 months after implant placement. These scans will be used to assess how the gum tissue changes in response to each type of abutment using 3D analysis and software-based measurements.
This study is important because maintaining healthy and stable soft tissue around dental implants plays a crucial role in achieving successful, long-lasting, and aesthetically pleasing results. By understanding how healing abutment design affects tissue healing, clinicians may be better equipped to select the most appropriate healing protocol for each patient.
Detailed description
Background and Rationale:
Peri-implant soft tissue health and stability are essential factors influencing the long-term success of dental implants, especially in terms of aesthetic outcomes and biological integration. A well-formed and stable mucosal seal around the implant protects the underlying bone, supports tissue homeostasis, and contributes to the overall functional and esthetic result of implant-supported prostheses.
Healing abutments are temporary components used during the transgingival healing phase to help shape the emergence profile and guide soft tissue adaptation prior to final prosthetic restoration. The design, diameter, and customization of the healing abutment may significantly affect peri-implant soft tissue volume, thickness, contour, and recession patterns. Recent research has suggested that minimizing disruption to the peri-implant mucosa (i.e., using a one abutment-one time approach) and optimizing soft tissue support during healing can result in improved tissue preservation and enhanced esthetic outcomes.
However, there is limited clinical evidence comparing the effect of different healing abutment designs-particularly standard, wide, and customized abutments-on the volumetric and linear changes in peri-implant soft tissues, especially when implants are placed subcrestally in healed ridges. This study aims to address that gap through a randomized controlled clinical trial using modern digital tools for volumetric analysis.
Study Objectives:
Primary Objective:
To compare the volumetric changes in peri-implant soft tissue among three different healing abutment designs (standard, wide, and customized) placed over subcrestally positioned bone-level implants in healed ridges.
Secondary Objectives:
To assess the linear changes in gingival margin position and mucosal thickness.
To evaluate the influence of healing abutment design on the stability of the emergence profile.
To explore potential correlations between abutment geometry and soft tissue recession or contour collapse.
To analyze patient-reported outcomes related to esthetic satisfaction and perceived tissue healing.
Study Design:
This is a single-center, randomized, controlled, parallel-group clinical trial with three intervention arms. Thirty adult patients will be recruited and randomly allocated into one of the three study groups (n = 25 per group). All patients will receive a single bone-level dental implant in a posterior maxillary or mandibular healed site, placed 2 mm subcrestally following a one abutment-one time protocol with platform switching.
Study Groups:
Group 1 (Control Group):
Standard cylindrical titanium healing abutment (prefabricated, regular diameter).
Group 2 (Wide Abutment Group):
Prefabricated wide healing abutment with increased diameter for broader mucosal support.
Group 3 (Customized Abutment Group):
Customized healing abutment fabricated in composite using preformed emergence profiles to replicate the ideal emergence profile of the final prosthesis.
All healing abutments will be placed at the time of implant surgery and will not be disconnected during the healing process, in accordance with the one abutment-one time philosophy.
Inclusion Criteria:
Adults aged 18 years or older.
Non-smoking or light-smoking patients (<10 cigarettes/day).
Good general and oral health.
Healed posterior edentulous site requiring a single implant.
Presence of ≥2 mm of keratinized mucosa.
Bone volume sufficient for subcrestal implant placement without grafting.
Willingness to participate and follow the study protocol.
Exclusion Criteria:
Active periodontal or peri-implant disease.
Systemic diseases affecting healing (e.g., uncontrolled diabetes).
Use of bisphosphonates or immunosuppressants.
Pregnancy or lactation.
History of radiation therapy in the head and neck.
Parafunctional habits (e.g., severe bruxism).
Intervention Protocol:
Surgical Procedure:
All implants will be placed 2 mm subcrestally using a guided surgical protocol.
After implant placement, patients will receive the assigned healing abutment (standard, wide, or customized) immediately.
The abutment will remain in place throughout healing and prosthetic phases.
Digital Workflow:
Intraoral scans (STL files) will be obtained at:
T0 (baseline, immediately post-surgery),
T1 (3 months),
T2 (6 months),
T3 (12 months).
The STL files will be superimposed using best-fit alignment algorithms for accurate 3D comparisons.
Tissue Measurement and Analysis:
Soft tissue changes will be measured in terms of:
Volumetric displacement (mm³) using specialized 3D software.
Linear changes in soft tissue thickness and mucosal margin level (mm).
Qualitative heat maps and color-coded deviations will be used to visualize soft tissue gain/loss.
Primary Outcome Measure:
Change in buccal soft tissue volume (mm³) from baseline to 3 months, based on digital 3D superimposition and volumetric analysis.
Secondary Outcome Measures:
Linear change in mucosal thickness (mm) at 3, 6, and 12 months.
Gingival margin displacement (mm) at buccal and interproximal points.
Stability of the emergence profile during provisional and final restoration stages.
Patient-reported esthetic satisfaction using a visual analog scale (VAS).
Statistical Analysis:
Descriptive and inferential statistics will be used. Continuous variables will be analyzed with repeated measures ANOVA or mixed models. Categorical variables will be evaluated using chi-square or Fisher's exact tests. A p-value < 0.05 will be considered statistically significant.
Sample size was calculated to detect a clinically significant difference of 1 mm³ in soft tissue volume change, with a standard deviation of 0.8, α = 0.05, and 80% power, resulting in 10 subjects per group.
Ethical Considerations:
The study will be conducted in accordance with the Declaration of Helsinki and Good Clinical Practice (GCP) guidelines. Ethical approval has been or will be obtained from the institutional review board. Informed consent will be obtained from all participants prior to any study-related procedure.
Expected Outcomes and Significance:
This clinical trial aims to clarify how the design of healing abutments-particularly customized CAD/CAM components-affects the healing and dimensional stability of peri-implant soft tissues. Results from this study could support evidence-based decision-making regarding abutment selection in clinical practice, especially in aesthetic-sensitive or high-demand cases. Improved tissue preservation could lead to better prosthetic outcomes and patient satisfaction.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Standard Healing Abutment Group | Experimental | Procedure: Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing AbutmentsParticipants in this group will receive a conventional, prefabricated cylindrical titanium healing abutment placed immediately after implant surgery. The abutment will remain in place throughout the healing period, following a one abutment-one time protocol. |
| Wide Healing Abutment Group | Experimental | Procedure: Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing AbutmentsParticipants in this group will receive a prefabricated wide healing abutment with an increased diameter designed to provide broader mucosal support. The abutment will be placed immediately after surgery and will not be removed during healing. |
| Customized Healing Abutment Group | Experimental | Procedure: Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing AbutmentsParticipants in this group will receive a customized healing abutment fabricated with composite using a preform-phantoma. The abutment will replicate the desired emergence profile of the final prosthesis. It will be placed immediately after surgery and left in place during the healing phase. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Adults aged 18 years or older.
- Patients requiring a single dental implant in a healed posterior site (maxilla or mandible).
- Presence of at least 2 mm of keratinized mucosa at the implant site.
- Healed alveolar ridge with sufficient bone volume for implant placement without need for guided bone regeneration.
- Good general and oral health, with controlled plaque and bleeding indices.
Key exclusion criteria (8 listed)
- Smoking more than 10 cigarettes per day.
- Uncontrolled systemic diseases (e.g., uncontrolled diabetes, immunosuppression).
- History of head or neck radiation therapy.
- Current or recent use of bisphosphonates.
- Active periodontal disease or peri-implant infection.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing AbutmentsAll participants will receive a single bone-level dental implant placed in a healed posterior site of the maxilla or mandible. The implants will be placed using a biological drilling protocol and inserted with a final torque of at least 30 Ncm. A 2 mm transmucosal one-piece abutment (mono-block) will be connected at the time of surgery, following a one abutment-one time philosophy. Each patient will receive a healing abutment immediately after implant placement according to their allocated study group (standard, wide, or customized). The assigned healing abutment will not be removed throughout the healing period. All procedures will be carried out under local anesthesia in a standard clinical setting. | Procedure or surgery | Customized Healing Abutment Group, Standard Healing Abutment Group, Wide Healing Abutment Group |
Primary outcome
Dimensional changes in the peri-implamt soft tissue
Time frame: Preoperative, the day of the intervention and a follow up until 12 months
Soft tissue changes will be assessed using digital intraoral scans obtained at baseline, immediately after surgery, and at 3, 6, and 12 months. STL files will be superimposed using 3D analysis software based on stable anatomical landmarks. Volumetric and linear changes will be calculated within defined buccal and interproximal regions of interest (ROIs). Parameters include soft tissue volume (mm³), thickness (mm), and gingival margin displacement. Color-coded deviation maps will visualize contour stability. All measurements will be performed in duplicate by calibrated, blinded evaluators. This method offers accurate, reproducible, and non-invasive assessment of peri-implant soft tissue dynamics.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jul 2026.
- Results publication: PubMed 31797548Perez A, Caiazzo A, Valente NA, Toti P, Alfonsi F, Barone A. Standard vs customized healing abutments with simultaneous bone grafting for tissue changes around immediate implants. 1-year outcomes from a randomized clinical trial. Clin Implant Dent Relat Res. 2020 Feb;22(1):42-53. doi: 10.1111/cid.12871. Epub 2019 Dec 3.
- Results publication: PubMed 38337580Chokaree P, Poovarodom P, Chaijareenont P, Rungsiyakull P. Effect of Customized and Prefabricated Healing Abutments on Peri-Implant Soft Tissue and Bone in Immediate Implant Sites: A Randomized Controlled Trial. J Clin Med. 2024 Feb 2;13(3):886. doi: 10.3390/jcm13030886.
- Results publication: PubMed 35318752Puisys A, Auzbikaviciute V, Vindasiute-Narbute E, Pranskunas M, Razukevicus D, Linkevicius T. Immediate implant placement vs. early implant treatment in the esthetic area. A 1-year randomized clinical trial. Clin Oral Implants Res. 2022 Jun;33(6):634-655. doi: 10.1111/clr.13924. Epub 2022 Apr 7.
- Results publication: PubMed 36155739Akin R, Chapple AG. Clinical Advantages of Immediate Posterior Implants With Custom Healing Abutments: Up to 8-Year Follow-Up of 115 Cases. J Oral Maxillofac Surg. 2022 Dec;80(12):1952-1965. doi: 10.1016/j.joms.2022.08.014. Epub 2022 Aug 30.
- Individual participant dataSharing planned: No
Related trials for Peri-implant Soft Tissue Healing
Not yet recruiting
Effect of Customized Versus Stock Healing Abutments on Peri-Implant Soft Tissue
Peri-Implantitis
Active, not recruiting
Healing Outcomes of Peri-implant Soft Tissues With Different Healing Abutments
Implant
Active, not recruiting
Clinical Assessment of UV Photofunctionalization on Stability and Osseointegration of Early Loaded Implants
Evaluating the Clinical Efficacy of Applying Ultraviolet Photofunctionalization (UV phF) to Standard Titanium Implants Immediately Before Surgery, Monitoring Early Implant Stability and Osseointegration During the Critical Initial Healing Phase
RecruitingObservational study
Immediate Molar Implants With Customized Healing Abutments in Different Post-Extraction Socket Classes
Tooth Loss, Alveolar Bone Loss
Recruiting
Soft Tissue Augmentation Around Dental Implants Using Connective Tissue Graft, Submerged Tenting Abutment, or Sub-crestal Implant Placement
Peri-implant Soft Tissue Deficiency, Partial Edentulism
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments in people with Peri-implant Soft Tissue Healing and Soft Tissue Management in Subcrestal Dental Implants, run by University of Valencia at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Dimensional changes in the peri-implamt soft tissue (time frame: Preoperative, the day of the intervention and a follow up until 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07031232, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.